Summary

The global Home Non-invasive Ventilation Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Non-invasive ventilation (NIV) is the use of breathing support administered through a face mask, nasal mask, or a helmet. Air, usually with added oxygen, is given through the mask under positive pressure; generally the amount of pressure is alternated depending on whether someone is breathing in or out. Non-invasive ventilation (NIV) devices include CPAP/APAP/BPAP devices, applied for the therapy of SDB (sleep disordered breathing) and respiratory insufficiency.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Home Non-invasive Ventilation Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
ResMed
Philips Respironics
Fisher & Paykel Healthcare
DeVilbiss Healthcare
Fosun Pharma
Covidien (Medtronic)
BMC Medical
Teijin Pharma
Apex Medical
Beyond Medical
Somnetics
Koike Medical
HuNan Beyond Medical
Jiangsu Yuyue medical
Kare Medical
3B Medical
Segment by Type
CPAP Devices
APAP Devices
BPAP Devices
Segment by Application
Homecare
Hospital
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Home Non-invasive Ventilation Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Home Non-invasive Ventilation Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Home Non-invasive Ventilation Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 CPAP Devices
1.2.3 APAP Devices
1.2.4 BPAP Devices
1.3 Market Segmentation by Application
1.3.1 Global Home Non-invasive Ventilation Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Homecare
1.3.3 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Home Non-invasive Ventilation Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Home Non-invasive Ventilation Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Home Non-invasive Ventilation Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Home Non-invasive Ventilation Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Home Non-invasive Ventilation Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Home Non-invasive Ventilation Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 CPAP Devices Market Size by Manufacturers
3.5.2 APAP Devices Market Size by Manufacturers
3.5.3 BPAP Devices Market Size by Manufacturers
3.6 Global Home Non-invasive Ventilation Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Home Non-invasive Ventilation Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Home Non-invasive Ventilation Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Home Non-invasive Ventilation Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Home Non-invasive Ventilation Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Home Non-invasive Ventilation Devices Sales and Revenue by Type (2020-2031)
6.4 North America Home Non-invasive Ventilation Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Home Non-invasive Ventilation Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Home Non-invasive Ventilation Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Home Non-invasive Ventilation Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Home Non-invasive Ventilation Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Home Non-invasive Ventilation Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Home Non-invasive Ventilation Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Home Non-invasive Ventilation Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Home Non-invasive Ventilation Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Home Non-invasive Ventilation Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Home Non-invasive Ventilation Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Home Non-invasive Ventilation Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Home Non-invasive Ventilation Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Home Non-invasive Ventilation Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 ResMed
11.1.1 ResMed Corporation Information
11.1.2 ResMed Business Overview
11.1.3 ResMed Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.1.4 ResMed Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 ResMed Home Non-invasive Ventilation Devices Sales by Product in 2024
11.1.6 ResMed Home Non-invasive Ventilation Devices Sales by Application in 2024
11.1.7 ResMed Home Non-invasive Ventilation Devices Sales by Geographic Area in 2024
11.1.8 ResMed Home Non-invasive Ventilation Devices SWOT Analysis
11.1.9 ResMed Recent Developments
11.2 Philips Respironics
11.2.1 Philips Respironics Corporation Information
11.2.2 Philips Respironics Business Overview
11.2.3 Philips Respironics Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.2.4 Philips Respironics Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Philips Respironics Home Non-invasive Ventilation Devices Sales by Product in 2024
11.2.6 Philips Respironics Home Non-invasive Ventilation Devices Sales by Application in 2024
11.2.7 Philips Respironics Home Non-invasive Ventilation Devices Sales by Geographic Area in 2024
11.2.8 Philips Respironics Home Non-invasive Ventilation Devices SWOT Analysis
11.2.9 Philips Respironics Recent Developments
11.3 Fisher & Paykel Healthcare
11.3.1 Fisher & Paykel Healthcare Corporation Information
11.3.2 Fisher & Paykel Healthcare Business Overview
11.3.3 Fisher & Paykel Healthcare Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.3.4 Fisher & Paykel Healthcare Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Fisher & Paykel Healthcare Home Non-invasive Ventilation Devices Sales by Product in 2024
11.3.6 Fisher & Paykel Healthcare Home Non-invasive Ventilation Devices Sales by Application in 2024
11.3.7 Fisher & Paykel Healthcare Home Non-invasive Ventilation Devices Sales by Geographic Area in 2024
11.3.8 Fisher & Paykel Healthcare Home Non-invasive Ventilation Devices SWOT Analysis
11.3.9 Fisher & Paykel Healthcare Recent Developments
11.4 DeVilbiss Healthcare
11.4.1 DeVilbiss Healthcare Corporation Information
11.4.2 DeVilbiss Healthcare Business Overview
11.4.3 DeVilbiss Healthcare Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.4.4 DeVilbiss Healthcare Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 DeVilbiss Healthcare Home Non-invasive Ventilation Devices Sales by Product in 2024
11.4.6 DeVilbiss Healthcare Home Non-invasive Ventilation Devices Sales by Application in 2024
11.4.7 DeVilbiss Healthcare Home Non-invasive Ventilation Devices Sales by Geographic Area in 2024
11.4.8 DeVilbiss Healthcare Home Non-invasive Ventilation Devices SWOT Analysis
11.4.9 DeVilbiss Healthcare Recent Developments
11.5 Fosun Pharma
11.5.1 Fosun Pharma Corporation Information
11.5.2 Fosun Pharma Business Overview
11.5.3 Fosun Pharma Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.5.4 Fosun Pharma Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Fosun Pharma Home Non-invasive Ventilation Devices Sales by Product in 2024
11.5.6 Fosun Pharma Home Non-invasive Ventilation Devices Sales by Application in 2024
11.5.7 Fosun Pharma Home Non-invasive Ventilation Devices Sales by Geographic Area in 2024
11.5.8 Fosun Pharma Home Non-invasive Ventilation Devices SWOT Analysis
11.5.9 Fosun Pharma Recent Developments
11.6 Covidien (Medtronic)
11.6.1 Covidien (Medtronic) Corporation Information
11.6.2 Covidien (Medtronic) Business Overview
11.6.3 Covidien (Medtronic) Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.6.4 Covidien (Medtronic) Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Covidien (Medtronic) Recent Developments
11.7 BMC Medical
11.7.1 BMC Medical Corporation Information
11.7.2 BMC Medical Business Overview
11.7.3 BMC Medical Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.7.4 BMC Medical Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 BMC Medical Recent Developments
11.8 Teijin Pharma
11.8.1 Teijin Pharma Corporation Information
11.8.2 Teijin Pharma Business Overview
11.8.3 Teijin Pharma Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.8.4 Teijin Pharma Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Teijin Pharma Recent Developments
11.9 Apex Medical
11.9.1 Apex Medical Corporation Information
11.9.2 Apex Medical Business Overview
11.9.3 Apex Medical Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.9.4 Apex Medical Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Apex Medical Recent Developments
11.10 Beyond Medical
11.10.1 Beyond Medical Corporation Information
11.10.2 Beyond Medical Business Overview
11.10.3 Beyond Medical Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.10.4 Beyond Medical Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Beyond Medical Recent Developments
11.11 Somnetics
11.11.1 Somnetics Corporation Information
11.11.2 Somnetics Business Overview
11.11.3 Somnetics Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.11.4 Somnetics Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Somnetics Recent Developments
11.12 Koike Medical
11.12.1 Koike Medical Corporation Information
11.12.2 Koike Medical Business Overview
11.12.3 Koike Medical Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.12.4 Koike Medical Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Koike Medical Recent Developments
11.13 HuNan Beyond Medical
11.13.1 HuNan Beyond Medical Corporation Information
11.13.2 HuNan Beyond Medical Business Overview
11.13.3 HuNan Beyond Medical Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.13.4 HuNan Beyond Medical Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 HuNan Beyond Medical Recent Developments
11.14 Jiangsu Yuyue medical
11.14.1 Jiangsu Yuyue medical Corporation Information
11.14.2 Jiangsu Yuyue medical Business Overview
11.14.3 Jiangsu Yuyue medical Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.14.4 Jiangsu Yuyue medical Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Jiangsu Yuyue medical Recent Developments
11.15 Kare Medical
11.15.1 Kare Medical Corporation Information
11.15.2 Kare Medical Business Overview
11.15.3 Kare Medical Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.15.4 Kare Medical Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Kare Medical Recent Developments
11.16 3B Medical
11.16.1 3B Medical Corporation Information
11.16.2 3B Medical Business Overview
11.16.3 3B Medical Home Non-invasive Ventilation Devices Product Models, Descriptions and Specifications
11.16.4 3B Medical Home Non-invasive Ventilation Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 3B Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Home Non-invasive Ventilation Devices Industry Chain
12.2 Home Non-invasive Ventilation Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Home Non-invasive Ventilation Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Home Non-invasive Ventilation Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Home Non-invasive Ventilation Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Home Non-invasive Ventilation Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details